Federal clearance in the US has pushed some cannabis acquisitions closer towards completion. 

On Wednesday (October 30), both Curaleaf Holdings (CSE:CURA,OTCQX:CURLF) and Cresco Labs (CSE:CL,OTCQX:CRLBF) revealed that the waiting periods under the Hart-Scott-Rodino Antitrust Improvements (HSR) Act have expired for their respective multimillion dollar acquisitions.

Though both of the deals are set to improve the two multi-state operators’ (MSOs) market share across the US and could represent a newfound interest in the regulated cannabis industry at the state level by federal powers, cannabis deals overall have been downsized in the face of a struggling market.

Curaleaf closes in on Select acquisition

Confirmation of Massachusetts-based Curaleaf’s deal with Select, a cannabis brand currently owned by Cura Partners, comes after investors first learned of the acquisition in May of this year.

The all-stock transaction was originally valued at US$948.8 million and included Select’s manufacturing, processing, distribution, retailing and marketing operations for recreational and medical cannabis.

The deal will help Curaleaf diversify geographically, allowing it to benefit from Select’s presence in key Western US states, including California, Arizona, Nevada and Select’s home state of Oregon.

The deal is now moving forward on amended terms, Curaleaf said on Wednesday (October 30), noting that current cannabis market conditions have pushed the two firms into mutually agreeing to reduce the base consideration payable once the transaction closes.

In the revised deal, Curaleaf has slashed the number of subordinate voting shares payable to 55 million, down from over 95 million. The difference in shares will be payable to Select’s equity holders on the condition that Curaleaf achieves a revenue target of between US$130 million and US$250 million in the 2020 calendar year; the target is based on previous Select-branded cannabis extract sales.

Select equity holders could also receive an earn out of up to US$200 million from the issuance of additional subordinate voting shares if Curaleaf rakes in more than US$300 million in revenue.

Though the transaction has been amended due to shifting market conditions, CEO Joseph Lusardi said in a statement that the deal remains a significant part of Curaleaf’s growth plan in the US.

“We remain extremely confident in the strength and operations of the Select business and of the long-term prospects of the cannabis sector as a whole,” Lusardi said.

The union of the two firms is set to close on January 1, 2020, subject to customary closing conditions and regulatory approvals.

Curaleaf also has its US$875 million acquisition of Grassroots coming down the pipeline.

During a panel at a recent investor event, Curaleaf Chairman Boris Jordan said the scrutiny from US Department of Justice antitrust officials on some of the larger deals in the cannabis space has been beneficial for the industry. The executive explained the federal agency has been cooperative and has used the review process to “get an education on the sector.”

Curaleaf experienced a 3.7 percent drop in value on Wednesday. It sat at C$6.81 as of 1:22 p.m. EDT.

Cresco gets clearance for a second deal

The HSR waiting period has also run up on Cresco Labs’ deal to acquire Tryke, a vertically integrated seed-to-sale cannabis firm with ownership of the Reef Dispensary store network in Nevada and Arizona.

The deal is set to be signed off on by the first half of 2020, according to the MSO. It was originally valued at US$252.5 million for Tryke’s operating assets, with an additional US$30 million for real estate for a total of US$282.5 million.

Like Curaleaf, Cresco Labs now has to wait to get the green light on closing conditions, including approval from Nevada, Arizona and Utah’s respective state governments.

“Upon the closing of the transaction, Cresco will have cultivation, processing, and retail assets in strategic and culturally significant legal states representing 71 percent of the US addressable cannabis market,” Cresco Labs CEO Charlie Bachtell said.

This is the second acquisition Cresco Labs has obtained federal clearance for in the past week.

Last Wednesday (October 23), the MSO confirmed similar clearance for its C$1.1 billion deal with Origin House (CSE:OH,OTCQX:ORHOF), first announced this past April.

The company touted it as the largest public company transaction in the US cannabis space at the time; the deal was originally set to be completed in June of this year.

The two companies are now working on writing new terms they can both agree on.

Cresco Labs’ share price fluctuated somewhat on Wednesday, and as of 1:20 p.m. EDT sat at C$8.47.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Danielle Edwards, hold no direct investment interest in any company mentioned in this article.

World-Class Extractions Inc. (CSE:PUMP)(FRA:WCF)(OTCQB:WCEXF) (the “Company” or “World-Class”), reports that it has sold its 50% interest in Cobra Ventures Inc. (“Cobra”), which sale included all funds previously advanced by World Class to Cobra, to the remaining shareholder of Cobra, for $2,500,000 in cash

An investment group led by Richard Goldstein retains 100% control of Cobra, and its senior secured debenture of Hydrx Farms Ltd. (“Hydrx”), acquired by Cobra in October 2020.

Keep reading... Show less

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced that Kurt Schmidt, President and Chief Executive Officer, will speak at the 24th Annual CIBC Western Institutional Investor Conference on Friday, January 22, 2021 at 4:10 p.m. EST.

A recording will be available on the Investors section of the Company’s website at https://ir.thecronosgroup.com/events-presentations .

Keep reading... Show less
  • Disease control of root-rot Aphanomyces zoospores in laboratory tests.
  • Outstanding Efficacy: 100% control at economic application rates within 24 hours.
  • Aphanomyces is a soil-borne root-rot disease that destroys peas, lentils, and legume crops.

MustGrow Biologics Corp. (CSE: MGRO) (OTC: MGROF) (FSE: 0C0) (the “Company”, “MustGrow”) is pleased to announce successful laboratory test results of its patented mustard-derived biopesticide on Aphanomyces euteiches zoospores (“Aphanomyces”) via an independent third party facility: 100% control at economic application rates within 24 hours. MustGrow will now advance to larger scale greenhouse and field tests. Study results and applicability are patent-protected under MustGrow’s existing suite of issued patents.

MustGrow’s remarkably safe and effective organic biopesticide is plant-based – harnessing the mustard seed’s natural defense mechanism to control diseases, pests, and weeds with an organic food-grade biopesticide.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or “the Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced the hiring of CPG industry veteran Ty Gent as the Company’s new Chief Operating Officer (“COO”). As COO, Gent will be responsible for operational consistency and efficiency across markets and implementation of structural enhancements to facilitate scaling.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210119005322/en/

Keep reading... Show less

HempFusion Wellness Inc. (TSX:CBD.U) (“ HempFusion ” or the “ Company ”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that its wholly owned subsidiary, Probulin Probiotics, LLC (“ Probulin ”), has increased its product selection in certain brick and mortar locations and expanded its distribution on Amazon through a unique eCommerce store within the Amazon platform. The broader product selection is available in major brick and mortar stores including Sprouts and Fresh Thyme and includes the Company’s new Probulin Total Care Immune product.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210119005411/en/

Keep reading... Show less